Health Care & Life Sciences » Pharmaceuticals | Alvogen Korea Co. Ltd.

Alvogen Korea Co. Ltd.

Alvogen Korea Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW1102
Market Cap
KRW322.54 B
Shares Outstanding
11.86 M
Public Float
920 K

Profile

Address
13/F, IFC Two
Seoul SL 07241
Korea, Republic Of
Employees -
Website http://www.Alvogenkorea.com
Updated 09/14/2018
Alvogen Korea Co., Ltd. engages in the manufacture of pharmaceutical products. It offers products for the therapeutic areas of endocrine system, urinary system, neuropsychiatry system, anti-inflammatory, antipyretic, analgesic, gastrointestinal system, cardiovascular system, dermatology, hepatitis, antibiotics, respiratory system, hormones etc. It provides pharmaceutical products in various dosage forms, including tablets, capsules, granules, powders, ampoules, vials and intravenous (IV) solutions.

Financials

View All
Created with Highcharts 5.0.14Alvogen Korea Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.2 0262 02610 68710 68712 24012 2408 6778 67710 39910 3992013201420152016201702.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Alvogen Korea Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.70 83370 83365 26265 262165 837165 837181 183181 183190 057190 05720132014201520162017050k100k150k200k

Young-Hee Chang
Chief Executive Officer & Director
Sung-Ho Jin
Director & Managing Director